Skip to main content

and
  1. No Access

    Article

    Atezolizumab addition to platinum doublet: evaluating survival outcomes for patients with extensive disease small cell lung cancer

    The efficacy of adding atezolizumab to the platinum doublet regimen for extensive disease small cell lung cancer (ED-SCLC) remains marginally limited.

    Sousuke Kubo, Nobuaki Kobayashi in Journal of Cancer Research and Clinical On… (2023)